VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis
First launches expected in H1 2022
First launches expected in H1 2022
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The stability is led by healthy demand in the domestic and emerging markets
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Subscribe To Our Newsletter & Stay Updated